NUCLEOTIDE EXCISION REPAIR PATHWAY (PW:0000130)
Description
DNA lesions, induced by endogenous or exogenous agents, affect the faithful replication of the genome resulting in genetic aberrations that can be deleterious to the cell and organism. Multiple systems have evolved to detect single and double-strand DNA lesions, initiate signals that can be amplified and propagated, and set in motion effectors that can impinge upon DNA repair and checkpoint, various signaling and/or regulatory pathways, as necessary. Together, this vast response mechanism is known as the DNA Damage Response (DDR) pathway whose elements may operate collectively with shared components. The nucleotide excision repair (NER) pathway, is a versatile single-strand DNA repair pathway and part of DDR. It targets various, structurally unrelated DNA modifications that result in distortion of the double helix. NER is subdivided into two sub-pathways that differ in the first step of lesion recognition. The transcription-coupled TC-NER is involved in the repair of lesions within the transcribed strand of active genes whereas the global genome GG-NER is involved in the repair of lesions throughout the genome. The two converge into the core of NER leading to cleavage of the damaged strand on either side of the lesion and excision of a stretch of about 24-32 nucleotides followed by re-synthesis of the missing DNA stretch and ligation. In TC-NER, the stalled RNA polymerase II (PolrII) complex acts as the damage sensor recruiting TC-NER specific factors of which Cackayne syndrome CSA and CSB, the Ercc8 and Ercc6 genes, play essential, but partially understood roles. Ercc6 binds stalled PolrII while Ercc8 interacts with Ercc6, Hmgn1, Xab2 and the Gtf2h2 subunit of TFIIH. Ercc6 has DNA-dependent ATPase activity, recruits histone acetyltransferases and in vitro, has chromatin remodeling activity. In GG-NER, lesions are recognized by Xpc within the Xpc-Rad23b-centrin2 complex and certain types of lesions by the UV-DDB complex (Ddb1-Ddb2-containing E3-ubiquitin ligase complex). The UV-DDB complex is thought to recognize nucleosomes containing the DNA lesion, play a role in chromatin modification. The C-terminus of Xpc interacts with Ercc3 and both termini are used in the interaction with Gtf2h1; the two are subunits of TFIIH. The mammalian TFIIH is a ten subunits complex and a component of the multi-protein pre-initiation complex (PIC) of RNA polymerase II transcription. TFIIH, primarily a Pol II factors, may also be involved in transcription by pol I and III. Ercc3 and another TFIIH subunit, Ercc2, known are XPB and XPD, respectively, are ATP-dependent helicases that open the damaged DNA, melting a region spanning ~30 nucleotides around the lesion. It is believed that DNA unwinding requires the helicase activity of Ercc2 and the ATPase activity of Ercc3 with the latter being regulated by Xpc. Subsequently, the Rpa trimeric complex together with Xpa are recruited; Rpa associates with single-stranded damaged DNA while Xpa, in addition to Rpa, also interacts with Xpc. Rpa stimulates recruitment of incision endonucleases Ercc4/XPF-Ercc1 complex and Ercc5/XPG. Ercc4-Ercc1 and Ercc5 cleave at the 5' and 3' to the lesion, respectively followed by release of Xpc and TFIIH. Rpa also interacts with and stimulates several DNA polymerases. Recruitment of Rfc complex, Pcna and DNA polymerase leads to release of Ercc4/XPF and initiation of repair synthesis which precedes the 3', Ercc5 mediated cleavage. Once Ercc5 is released, Rpa and the excised DNA fragment are also released. DNA synthesis s carried out by DNA polymerases delta, epsilon or kappa, depending on the state of the cell. Pcna is a trimeric clamp - a ring-shaped structure known to increase the processivity of replicative DNA polymerases and also needed in repair. Clamp assembly relies on the ATP-dependent action of the clamp loader ¿ the pentameric Rfc complex. The strand is sealed by DNA ligase Lig1 or Lig3-Xrcc1 complex. Post translational modifications (PMT) of molecules involved in NER and of histones, affect the proceedings of the pathway. Histone are components of chromatin whose relatively relaxed or compacted structure promotes or impedes access to DNA, respectively. Chromatin modification/remodeling is an integral part of DDR pathway. The ¿access-repair-restore¿ is the proposed model of DNA repair in the context of chromatin. Some NER proteins can modify chromatin and/or interact with modifiers or remodelers. Components of NER can also play a role in transcription, irrespective of genotoxic damage. In humans, inborn defects in several NER proteins, have been associated with skin cancer-prone and premature aging-like diseases.
To see the ontology report for Gviewer, annotations and download, click here ...(less)
Pathway Diagram:
Genes in Pathway:
G
Ccnh
cyclin H
IEA
KEGG
rno:03420
NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:17,570,263...17,614,860
G
Cdk7
cyclin-dependent kinase 7
IEA
KEGG
rno:03420
NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:33,574,623...33,599,485
G
Cetn2
centrin 2
IEA ISO
KEGG RGD
PMID:22572993
rno:03420, RGD:7246920
NCBI chr X:155,812,212...155,817,186
Ensembl chr X:155,812,003...155,817,744
G
Cul4a
cullin 4A
IEA
KEGG
rno:03420
NCBI chr16:83,086,688...83,124,503
Ensembl chr16:83,086,921...83,124,457
G
Cul4b
cullin 4B
IEA
KEGG
rno:03420
NCBI chr X:122,154,332...122,192,299
Ensembl chr X:122,154,332...122,192,299
G
Ddb1
damage-specific DNA binding protein 1
IEA ISO
KEGG RGD
PMID:22572993
rno:03420, RGD:7246920
NCBI chr 1:216,677,810...216,703,605
Ensembl chr 1:216,677,810...216,703,596
G
Ddb2
damage specific DNA binding protein 2
ISO
RGD
PMID:22572993
RGD:7246920
NCBI chr 3:97,640,923...97,667,617
Ensembl chr 3:97,640,579...97,664,066
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
IEA ISO
KEGG RGD
PMID:19154342
rno:03420, RGD:7246926
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
IEA ISO
KEGG SMPDB RGD
PMID:22572993
SMP:00478 rno:03420, RGD:7246920
NCBI chr 1:88,161,342...88,175,102
Ensembl chr 1:88,160,988...88,175,102
G
Ercc3
ERCC excision repair 3, TFIIH core complex helicase subunit
IEA ISO
KEGG RGD
PMID:22572993
rno:03420, RGD:7246920
NCBI chr18:24,157,831...24,188,543
Ensembl chr18:24,148,084...24,190,898
G
Ercc4
ERCC excision repair 4, endonuclease catalytic subunit
IEA ISO
KEGG SMPDB RGD
PMID:19154342
SMP:00478 rno:03420, RGD:7246926
NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,920,455...2,955,539
G
Ercc4l1
excision repair cross-complementing rodent repair deficiency, complementation group 4-like 1
IEA
KEGG
rno:03420
NCBI chr10:1,462,146...1,500,409
Ensembl chr10:1,462,197...1,490,393
G
Ercc5
ERCC excision repair 5, endonuclease
IEA ISO
KEGG SMPDB RGD
PMID:19154342
SMP:00478 rno:03420, RGD:7246926
NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084
G
Ercc6
ERCC excision repair 6, chromatin remodeling factor
IEA ISO
KEGG RGD
PMID:18166977 PMID:22824526
rno:03420, RGD:7246923 , RGD:7246919
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,771,581...7,841,895
G
Ercc8
ERCC excision repair 8, CSA ubiquitin ligase complex subunit
IEA ISO
KEGG RGD
PMID:18166977 PMID:22824526
rno:03420, RGD:7246923 , RGD:7246919
NCBI chr 2:41,380,901...41,418,294
Ensembl chr 2:41,380,901...41,418,294
G
Gtf2h1
general transcription factor IIH subunit 1
IEA ISO
KEGG RGD
PMID:22572993
rno:03420, RGD:7246920
NCBI chr 1:106,457,692...106,485,729
Ensembl chr 1:106,457,394...106,485,727
G
Gtf2h2
general transcription factor IIH subunit 2
IEA ISO
KEGG RGD
PMID:21763452
rno:03420, RGD:7246922
NCBI chr 2:33,358,863...33,386,726
Ensembl chr 2:33,358,869...33,386,688
G
Gtf2h3
general transcription factor IIH subunit 3
IEA
KEGG
rno:03420
NCBI chr12:37,669,995...37,687,505
Ensembl chr12:37,669,997...37,686,466
G
Gtf2h4
general transcription factor 2H subunit 4
IEA
KEGG
rno:03420
NCBI chr20:3,076,110...3,081,805
Ensembl chr20:3,076,088...3,081,760
G
Gtf2h5
general transcription factor IIH subunit 5
IEA
KEGG
rno:03420
NCBI chr 1:49,061,904...49,068,612
Ensembl chr 1:49,061,959...49,070,039
G
Hmgn1
high mobility group nucleosome binding domain 1
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr11:48,891,813...48,897,732
Ensembl chr11:48,891,814...48,897,771
G
Lig1
DNA ligase 1
IEA ISO
KEGG SMPDB RGD
PMID: PMID:21601536
SMP:00478 rno:03420, RGD:1358139 , RGD:7246935
NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708
G
Lig3
DNA ligase 3
ISO
RGD
PMID:21601536
RGD:7246935
NCBI chr10:68,215,371...68,238,705
Ensembl chr10:68,215,407...68,238,704
G
Mnat1
MNAT1 component of CDK activating kinase
IEA
KEGG
rno:03420
NCBI chr 6:97,550,566...97,706,598
Ensembl chr 6:97,550,543...97,706,595
G
Pcna
proliferating cell nuclear antigen
IEA ISO
KEGG SMPDB RGD
PMID:17512402 PMID:23545418
SMP:00478 rno:03420, RGD:7246931 , RGD:7246932
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
G
Pold1
DNA polymerase delta 1, catalytic subunit
IEA ISO
KEGG RGD
PMID: PMID:21601536
rno:03420, RGD:1358139 , RGD:7246935
NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:104,162,016...104,172,982
G
Pold2
DNA polymerase delta 2, accessory subunit
IEA ISO
KEGG RGD
PMID:21601536
rno:03420, RGD:7246935
NCBI chr14:84,962,933...84,969,148
Ensembl chr14:84,962,022...84,967,874
G
Pold3
DNA polymerase delta 3, accessory subunit
IEA ISO
KEGG RGD
PMID:21601536
rno:03420, RGD:7246935
NCBI chr 1:163,830,217...163,870,015
Ensembl chr 1:163,830,437...163,869,202
G
Pold4
DNA polymerase delta 4, accessory subunit
IEA ISO
KEGG RGD
PMID:21601536
rno:03420, RGD:7246935
NCBI chr 1:210,956,110...210,957,863
Ensembl chr 1:210,956,099...210,957,860
G
Pole
DNA polymerase epsilon, catalytic subunit
IEA ISO
KEGG SMPDB RGD
PMID:12806123 PMID:21601536
SMP:00478 rno:03420, RGD:7246936 , RGD:7246935
NCBI chr12:52,005,155...52,053,761
Ensembl chr12:52,005,155...52,053,662
G
Pole2
DNA polymerase epsilon 2, accessory subunit
IEA ISO
KEGG RGD
PMID:12806123
rno:03420, RGD:7246936
NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:93,410,758...93,435,361
G
Pole3
DNA polymerase epsilon 3, accessory subunit
IEA ISO
KEGG RGD
PMID:12806123
rno:03420, RGD:7246936
NCBI chr 5:80,989,508...80,992,742
Ensembl chr 5:80,989,511...80,992,742 Ensembl chr 7:80,989,511...80,992,742
G
Pole3-ps3
DNA polymerase epsilon 3, accessory subunit, pseudogene 3
ISO
RGD
PMID:12806123
RGD:7246936
NCBI chr 7:111,116,690...111,117,395
Ensembl chr 7:111,109,080...111,131,961
G
Pole4
DNA polymerase epsilon 4, accessory subunit
IEA ISO
KEGG RGD
PMID:12806123
rno:03420, RGD:7246936
NCBI chr 4:116,723,040...116,728,873
Ensembl chr 4:116,716,719...116,728,851
G
Polk
DNA polymerase kappa
ISO
RGD
PMID:21601536
RGD:7246935
NCBI chr 2:29,556,831...29,616,960
Ensembl chr 2:29,557,336...29,616,960
G
Polr1a
RNA polymerase I subunit A
ISO
SMPDB
SMP:00478
NCBI chr 4:105,508,305...105,572,272
Ensembl chr 4:105,508,248...105,574,036
G
Rad23a
RAD23 nucleotide excision repair protein A
IEA ISO
KEGG SMPDB
SMP:00478 rno:03420
NCBI chr19:40,219,235...40,225,543
Ensembl chr19:40,219,636...40,225,543
G
Rad23b
RAD23 nucleotide excision repair protein B
IEA ISO
KEGG RGD
PMID:22572993
rno:03420, RGD:7246920
NCBI chr 5:74,885,518...74,923,621
Ensembl chr 5:74,885,516...74,962,426
G
Rbx1
ring-box 1
IEA
KEGG
rno:03420
NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:114,870,972...114,881,191
G
Rfc1
replication factor C subunit 1
IEA ISO
KEGG SMPDB RGD
PMID:23545418
SMP:00478 rno:03420, RGD:7246932
NCBI chr14:43,319,768...43,395,028
Ensembl chr14:43,319,935...43,395,026
G
Rfc2
replication factor C subunit 2
IEA ISO
KEGG RGD
PMID:23545418
rno:03420, RGD:7246932
NCBI chr12:27,756,920...27,770,049
Ensembl chr12:27,756,922...27,770,025
G
Rfc3
replication factor C subunit 3
IEA ISO
KEGG RGD
PMID:23545418
rno:03420, RGD:7246932
NCBI chr12:5,836,546...5,847,331
Ensembl chr12:5,836,553...5,847,340
G
Rfc4
replication factor C subunit 4
IEA ISO
KEGG RGD
PMID:23545418
rno:03420, RGD:7246932
NCBI chr11:91,254,273...91,268,727
Ensembl chr11:91,254,243...91,268,730
G
Rfc5
replication factor C subunit 5
IEA ISO
KEGG RGD
PMID:23545418
rno:03420, RGD:7246932
NCBI chr12:44,868,322...44,877,879
Ensembl chr12:44,862,329...44,878,151
G
Rpa1
replication protein A1
IEA ISO
KEGG RGD
PMID:19154342
rno:03420, RGD:7246926
NCBI chr10:60,647,185...60,698,279
Ensembl chr10:60,647,185...60,698,279
G
Rpa2
replication protein A2
IEA ISO
KEGG RGD
PMID:19154342
rno:03420, RGD:7246926
NCBI chr 5:150,260,668...150,271,329
Ensembl chr 5:150,260,723...150,271,546
G
Rpa3
replication protein A3
IEA ISO
KEGG RGD
PMID:19154342
rno:03420, RGD:7246926
NCBI chr 4:37,270,966...37,273,997
Ensembl chr 4:37,270,966...37,274,183
G
Tent4a
terminal nucleotidyltransferase 4A
ISO
SMPDB
SMP:00478
NCBI chr 1:35,594,380...35,627,836
Ensembl chr 1:35,594,380...35,627,836
G
Xab2
XPA binding protein 2
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr12:6,465,569...6,477,616
Ensembl chr12:6,465,570...6,477,573
G
Xpa
XPA, DNA damage recognition and repair factor
IEA ISO
KEGG SMPDB RGD
PMID:19154342
SMP:00478 rno:03420, RGD:7246926
NCBI chr 5:65,227,281...65,275,784
Ensembl chr 5:65,227,281...65,272,425
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
IEA ISO
KEGG RGD
PMID:21763452 PMID:22572993
rno:03420, RGD:7246922 , RGD:7246920
NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305
G
Xrcc1
X-ray repair cross complementing 1
ISO
RGD
PMID:21601536
RGD:7246935
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613
G
Ddb1
damage-specific DNA binding protein 1
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr 1:216,677,810...216,703,605
Ensembl chr 1:216,677,810...216,703,596
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr 1:88,161,342...88,175,102
Ensembl chr 1:88,160,988...88,175,102
G
Ercc3
ERCC excision repair 3, TFIIH core complex helicase subunit
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr18:24,157,831...24,188,543
Ensembl chr18:24,148,084...24,190,898
G
Ercc4
ERCC excision repair 4, endonuclease catalytic subunit
ISO
in silico assessment of alteration of DNA-protein, protein-protein interactions and observed reduction of DNA repair capacity in the context of nucleotide excision repair pathway for SNP
RGD
PMID:22824526 PMID:24004570
RGD:7246919 , RGD:9588971
NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,920,455...2,955,539
G
Ercc5
ERCC excision repair 5, endonuclease
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084
G
Ercc6
ERCC excision repair 6, chromatin remodeling factor
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,771,581...7,841,895
G
Ercc8
ERCC excision repair 8, CSA ubiquitin ligase complex subunit
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr 2:41,380,901...41,418,294
Ensembl chr 2:41,380,901...41,418,294
G
Xpa
XPA, DNA damage recognition and repair factor
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr 5:65,227,281...65,275,784
Ensembl chr 5:65,227,281...65,272,425
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
ISO
RGD
PMID:22824526
RGD:7246919
NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305
Altered Pathway:
Pathway Gene Annotations
Disease Annotations Associated with Genes in the nucleotide excision repair pathway
Ccnh Animal Mammary Neoplasms , basal cell carcinoma , Breast Neoplasms , Capillary Malformation-Arteriovenous Malformation , carcinoma , Colonic Neoplasms , Esophageal Neoplasms , Experimental Mammary Neoplasms , glioblastoma , Liver Neoplasms , lung non-small cell carcinoma , Lymphatic Metastasis , Ovarian Neoplasms , Prostatic Neoplasms , Spinal Cord Injuries , Sturge-Weber syndrome , transient cerebral ischemia Cdk7 Alzheimer's disease Cul4a atrial fibrillation , Stevens-Johnson syndrome Cul4b Asthenozoospermia , Developmental Disabilities , Dwarfism , epilepsy , genetic disease , intellectual disability , oligospermia , syndromic X-linked intellectual disability 5 , syndromic X-linked intellectual disability Cabezas type , Teratozoospermia Ddb1 Chemical and Drug Induced Liver Injury , communication disorder , congenital heart disease , Disease Progression , Stomach Neoplasms , syndromic intellectual disability , WHITE-KERNOHAN SYNDROME , xeroderma pigmentosum Ddb2 genetic disease , ovarian cancer , xeroderma pigmentosum , xeroderma pigmentosum group E Ercc1 acute lymphoblastic leukemia , acute myeloid leukemia , alcohol use disorder , anemia , Arsenic Poisoning , azoospermia , breast cancer , cerebrooculofacioskeletal syndrome 4 , Chromosome Aberrations , Cockayne syndrome , colorectal cancer , Colorectal Neoplasms , degenerative disc disease , disease of cellular proliferation , Drug-induced Neutropenia , Drug-Related Side Effects and Adverse Reactions , esophagus adenocarcinoma , esophagus squamous cell carcinoma , Experimental Diabetes Mellitus , Failure to Thrive , Gastrointestinal Neoplasms , Genetic Predisposition to Disease , Germ Cell and Embryonal Neoplasms , hepatocellular carcinoma , high grade glioma , Inflammation , kidney failure , Laryngeal Neoplasms , lipodystrophy , lung adenocarcinoma , lung carcinoma , Lung Neoplasms , lung non-small cell carcinoma , melanoma , multiple myeloma , myelofibrosis , Myeloid Leukemia, Chronic-Phase , Neoplasm Metastasis , osteoarthritis , osteoporosis , osteosarcoma , ovarian cancer , ovary epithelial cancer , pancreatic cancer , peripheral nervous system disease , Premature Aging , Prostatic Neoplasms , Reperfusion Injury , stomach cancer , Stomach Neoplasms , Testicular Neoplasms , transient cerebral ischemia , Uterine Cervical Neoplasms , XFE progeroid syndrome Ercc2 acoustic neuroma , acquired immunodeficiency syndrome , acute leukemia , acute lymphoblastic leukemia , acute myeloid leukemia , Agenesis of Corpus Callosum , Alzheimer's disease , Anthracycline-induced Cardiotoxicity , asphyxia neonatorum , autosomal recessive congenital ichthyosis , B-Cell Chronic Lymphocytic Leukemia , breast cancer , Breast Neoplasms , cataract , cerebrooculofacioskeletal syndrome 1 , cerebrooculofacioskeletal syndrome 2 , Chromosome Aberrations , chronic myeloid leukemia , Cockayne syndrome , colorectal cancer , Colorectal Neoplasms , Congenital Ichthyosis with Trichothiodystrophy , coronary artery disease , Crohn's disease , Down syndrome , Drug-induced Neutropenia , Drug-Related Side Effects and Adverse Reactions , Endometrial Neoplasms , epidermolytic hyperkeratosis , Gallbladder Neoplasms , genetic disease , Head and Neck Neoplasms , hepatoblastoma , hepatocellular carcinoma , high grade glioma , hypotrichosis 1 , inflammatory bowel disease 1 , leukodystrophy , Lung Neoplasms , lung non-small cell carcinoma , macular degeneration , melanoma , Mouth Neoplasms , multiple myeloma , myelodysplastic syndrome , myelofibrosis , Occupational Diseases , oral mucosa leukoplakia , ovarian cancer , Ovarian Neoplasms , ovary epithelial cancer , pancreatic cancer , photosensitive trichothiodystrophy , photosensitive trichothiodystrophy 1 , prostate cancer , Prostatic Neoplasms , senile cataract , Skin Abnormalities , skin disease , Skin Neoplasms , squamous cell carcinoma , stomach cancer , Stomach Neoplasms , Sunburn , trichothiodystrophy , urinary bladder cancer , xeroderma pigmentosum , xeroderma pigmentosum group C , xeroderma pigmentosum group D Ercc3 Alzheimer's disease , Arsenic Poisoning , asphyxia neonatorum , Cockayne syndrome , colorectal cancer , Down syndrome , genetic disease , Hereditary Neoplastic Syndromes , Lung Neoplasms , lung non-small cell carcinoma , ovarian cancer , peripheral nervous system disease , photosensitive trichothiodystrophy 2 , trichothiodystrophy , xeroderma pigmentosum , xeroderma pigmentosum group B Ercc4 Arsenic Poisoning , autosomal recessive cerebellar ataxia , B-cell acute lymphoblastic leukemia , breast carcinoma , Cockayne syndrome , colorectal cancer , Experimental Diabetes Mellitus , Fanconi anemia complementation group Q , genetic disease , Genetic Predisposition to Disease , Germ Cell and Embryonal Neoplasms , Hereditary Neoplastic Syndromes , microcephaly , Micronuclei, Chromosome-Defective , Neoplasm Metastasis , ovarian cancer , pancreatic cancer , pancreatic carcinoma , peripheral nervous system disease , polyneuropathy due to drug , progeria , Recurrence , spastic ataxia , Spinocerebellar Ataxias , stomach cancer , Testicular Neoplasms , urinary bladder cancer , xeroderma pigmentosum , xeroderma pigmentosum group F , XFE progeroid syndrome Ercc5 cerebrooculofacioskeletal syndrome 3 , Cockayne syndrome , Colorectal Neoplasms , coronary artery disease , diffuse gastric cancer , disease by infectious agent , Genetic Predisposition to Disease , Hereditary Neoplastic Syndromes , high grade glioma , larynx cancer , lung cancer , lung non-small cell carcinoma , melanoma , stomach cancer , xeroderma pigmentosum , xeroderma pigmentosum group G Ercc6 age related macular degeneration 5 , Agenesis of Corpus Callosum , arthrogryposis multiplex congenita , cataract , cerebrooculofacioskeletal syndrome , cerebrooculofacioskeletal syndrome 1 , Cockayne syndrome , Cockayne syndrome B , colorectal adenocarcinoma , colorectal cancer , colorectal carcinoma , Craniofacial Abnormalities , De Sanctis-Cacchione syndrome , Drug-induced Neutropenia , fibrosarcoma , fragile X syndrome , genetic disease , Growth Disorders , Hearing Loss , hereditary breast ovarian cancer syndrome , larynx cancer , lung adenocarcinoma , lung cancer , lung carcinoma , Lung Neoplasms , lung non-small cell carcinoma , lung squamous cell carcinoma , lymphoma , macular degeneration , microcephaly , microphthalmia , middle cerebral artery infarction , Nijmegen breakage syndrome , polyneuropathy due to drug , Premature Aging , primary ovarian insufficiency 11 , primary ovarian insufficiency 16 , Psychomotor Disorders , sensorineural hearing loss , squamous cell carcinoma , stomach cancer , transient cerebral ischemia , UV-sensitive syndrome , UV-Sensitive Syndrome 1 Ercc8 autosomal recessive nonsyndromic deafness 1A , Cockayne syndrome , Cockayne syndrome A , genetic disease , hereditary breast ovarian cancer syndrome , Leigh disease , Nervous System Malformations , retinal disease , sensorineural hearing loss , UV-sensitive syndrome , UV-Sensitive Syndrome 2 Gtf2h1 Asthenozoospermia , oligospermia , Teratozoospermia Gtf2h5 genetic disease , photosensitive trichothiodystrophy 1 , photosensitive trichothiodystrophy 3 Hmgn1 Neoplastic Cell Transformation Lig1 epilepsy with generalized tonic-clonic seizures , immunodeficiency 96 , inherited metabolic disorder , primary immunodeficiency disease , urinary bladder cancer Lig3 Cardiac Arrhythmias , genetic disease , middle cerebral artery infarction , mitochondrial DNA depletion syndrome 20 , pancreatic cancer Pcna adenocarcinoma , alcohol-associated liver disease , Ataxia Telangiectasia Like Disorder , ataxia-telangiectasia-like disorder 2 , brain ischemia , Brain Neoplasms , Breast Neoplasms , Carotid Artery Injuries , Chagas Cardiomyopathy , Colonic Neoplasms , Experimental Mammary Neoplasms , Experimental Neoplasms , Experimental Radiation Injuries , focal segmental glomerulosclerosis , Germ Cell and Embryonal Neoplasms , hepatoblastoma , hepatocellular carcinoma , hypothyroidism , Intimal Hyperplasia , invasive ductal carcinoma , ischemia , leiomyoma , Lewy body dementia , liver cancer , Liver Injury , Lung Neoplasms , mucositis , Neoplasm Metastasis , nephroblastoma , obstructive jaundice , osteoporosis , Phyllodes Tumor , psoriasis , Pulmonary Hypertension, Hypoxia-Induced , renal cell carcinoma , sciatic neuropathy , seminoma , stomach cancer , Testicular Neoplasms , transient cerebral ischemia Pold1 bile duct cancer , breast cancer , colon cancer , colon carcinoma , colorectal cancer , Colorectal Cancer 10 , colorectal carcinoma , Colorectal Neoplasms , combined immunodeficiency , congenital myopathy 1A , Deafness , Drug-induced Neutropenia , endometrial carcinoma , Endometrial Neoplasms , familial adenomatous polyposis , familial adenomatous polyposis 2 , Hereditary Neoplastic Syndromes , hypogonadism , immunodeficiency 120 , intellectual disability , Jaw Abnormalities , lipodystrophy , lung adenocarcinoma , Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome , Micrognathism , Multiple Abnormalities , ovarian cancer , pancreatic carcinoma Pold3 Colorectal Neoplasms , immunodeficiency 122 Pold4 intellectual disability Pole ascending colon cancer , astroblastoma , breast cancer , Breast Neoplasms , colon cancer , colon carcinoma , colorectal cancer , Colorectal Cancer 10 , colorectal carcinoma , Colorectal Neoplasms , congenital myopathy 1A , Desbuquois dysplasia , endometrial cancer , endometrial carcinoma , Endometrioid Carcinomas , Facial Dysmorphism, Immunodeficiency, Livedo, and Short Stature , familial adenomatous polyposis , familial adenomatous polyposis 2 , Hereditary Neoplastic Syndromes , high grade glioma , IMAGEI Syndrome , lung cancer , lung non-small cell carcinoma , lung squamous cell carcinoma , mismatch repair cancer syndrome , myoepithelioma , ovarian cancer , XFE progeroid syndrome Polk epilepsy , glioblastoma , Micronuclei, Chromosome-Defective , prostate cancer , Prostatic Neoplasms Polr1a acrofacial dysostosis Cincinnati type , Desbuquois dysplasia , genetic disease , Hypomyelinating Leukodystrophy 27 , NESCAV syndrome Rad23a Disease Progression , Stomach Neoplasms Rad23b Craniofacial Abnormalities , male infertility , Prostatic Neoplasms Rbx1 Rubinstein-Taybi syndrome , Stevens-Johnson syndrome Rfc1 Bilateral Vestibulopathy , cerebellar ataxia , Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome , Colonic Neoplasms , congenital heart disease , genetic disease , hereditary breast ovarian cancer syndrome , motor peripheral neuropathy , osteosarcoma , primary pulmonary hypertension , Right Ventricular Hypertrophy , West Nile fever Rfc4 Animal Disease Models , lung adenocarcinoma , MORIMOTO-RYU-MALICDAN NEUROMUSCULAR SYNDROME Rpa1 Chloracne , Pulmonary Fibrosis and/or Bone Marrow Failure Syndrome, Telomere-Related, 6 Xpa basal cell carcinoma , Cockayne syndrome , genetic disease , Intestinal Neoplasms , Liver Neoplasms , Micronuclei, Chromosome-Defective , ovarian cancer , Skin Neoplasms , xeroderma pigmentosum , xeroderma pigmentosum group A Xpc amino acid metabolic disorder , autistic disorder , Chromosome Aberrations , Disease Progression , genetic disease , Hereditary Neoplastic Syndromes , Liver Neoplasms , lung adenocarcinoma , lung cancer , Lung Neoplasms , lung non-small cell carcinoma , Micronuclei, Chromosome-Defective , Neoplasm Invasiveness , Neoplasm Metastasis , ovarian cancer , pancreatic cancer , serous cystadenocarcinoma , squamous cell carcinoma , xeroderma pigmentosum , xeroderma pigmentosum group A , xeroderma pigmentosum group C Xrcc1 5 Alpha Fluorouracil Toxicity , acute lymphoblastic leukemia , asphyxia neonatorum , autosomal recessive spinocerebellar ataxia 26 , B-Cell Chronic Lymphocytic Leukemia , Birth Weight , brain glioma , Breast Neoplasms , cataract , central nervous system cancer , cervical cancer , Chemical and Drug Induced Liver Injury , Chronic Hepatitis C , chronic myeloid leukemia , colorectal adenocarcinoma , colorectal cancer , colorectal carcinoma , contact dermatitis , coronary artery disease , diabetic retinopathy , Erythema , esophageal cancer , esophagus squamous cell carcinoma , Experimental Seizures , gallbladder cancer , gastric cardia adenocarcinoma , gastric cardia carcinoma , glioblastoma , hepatitis A , hepatitis B , hepatocellular carcinoma , high grade glioma , Human Viral Hepatitis , hypertension , impotence , in situ carcinoma , invasive ductal carcinoma , laryngeal carcinoma , laryngeal squamous cell carcinoma , leiomyoma , liver cancer , liver cirrhosis , lung adenocarcinoma , lung cancer , lung non-small cell carcinoma , male infertility , malignant mesothelioma , meningioma , Mesothelioma , Micronuclei, Chromosome-Defective , middle cerebral artery infarction , Mouth Neoplasms , myelodysplastic syndrome , nasopharynx carcinoma , Neoplasm Metastasis , Occupational Diseases , oral mucosa leukoplakia , pancreatic cancer , papillary thyroid carcinoma , prostate cancer , Prostatic Neoplasms , renal cell carcinoma , Salivary Gland Neoplasms , seminoma , senile cataract , stomach cancer , stomach carcinoma , Stomach Neoplasms , stomatitis , transient cerebral ischemia , transitional cell carcinoma , type 2 diabetes mellitus , urinary bladder cancer
5 Alpha Fluorouracil Toxicity Xrcc1 acoustic neuroma Ercc2 acquired immunodeficiency syndrome Ercc2 acrofacial dysostosis Cincinnati type Polr1a acute leukemia Ercc2 acute lymphoblastic leukemia Ercc1 , Ercc2 , Xrcc1 acute myeloid leukemia Ercc1 , Ercc2 adenocarcinoma Pcna age related macular degeneration 5 Ercc6 Agenesis of Corpus Callosum Ercc2 , Ercc6 alcohol use disorder Ercc1 alcohol-associated liver disease Pcna Alzheimer's disease Cdk7 , Ercc2 , Ercc3 amino acid metabolic disorder Xpc anemia Ercc1 Animal Disease Models Rfc4 Animal Mammary Neoplasms Ccnh Anthracycline-induced Cardiotoxicity Ercc2 Arsenic Poisoning Ercc1 , Ercc3 , Ercc4 arthrogryposis multiplex congenita Ercc6 ascending colon cancer Pole asphyxia neonatorum Ercc2 , Ercc3 , Xrcc1 Asthenozoospermia Cul4b , Gtf2h1 astroblastoma Pole Ataxia Telangiectasia Like Disorder Pcna ataxia-telangiectasia-like disorder 2 Pcna atrial fibrillation Cul4a autistic disorder Xpc autosomal recessive cerebellar ataxia Ercc4 autosomal recessive congenital ichthyosis Ercc2 autosomal recessive nonsyndromic deafness 1A Ercc8 autosomal recessive spinocerebellar ataxia 26 Xrcc1 azoospermia Ercc1 B-cell acute lymphoblastic leukemia Ercc4 B-Cell Chronic Lymphocytic Leukemia Ercc2 , Xrcc1 basal cell carcinoma Ccnh , Xpa Bilateral Vestibulopathy Rfc1 bile duct cancer Pold1 Birth Weight Xrcc1 brain glioma Xrcc1 brain ischemia Pcna Brain Neoplasms Pcna breast cancer Ercc1 , Ercc2 , Pold1 , Pole breast carcinoma Ercc4 Breast Neoplasms Ccnh , Ercc2 , Pcna , Pole , Xrcc1 Capillary Malformation-Arteriovenous Malformation Ccnh carcinoma Ccnh Cardiac Arrhythmias Lig3 Carotid Artery Injuries Pcna cataract Ercc2 , Ercc6 , Xrcc1 central nervous system cancer Xrcc1 cerebellar ataxia Rfc1 Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome Rfc1 cerebrooculofacioskeletal syndrome Ercc6 cerebrooculofacioskeletal syndrome 1 Ercc2 , Ercc6 cerebrooculofacioskeletal syndrome 2 Ercc2 cerebrooculofacioskeletal syndrome 3 Ercc5 cerebrooculofacioskeletal syndrome 4 Ercc1 cervical cancer Xrcc1 Chagas Cardiomyopathy Pcna Chemical and Drug Induced Liver Injury Ddb1 , Xrcc1 Chloracne Rpa1 Chromosome Aberrations Ercc1 , Ercc2 , Xpc Chronic Hepatitis C Xrcc1 chronic myeloid leukemia Ercc2 , Xrcc1 Cockayne syndrome Ercc1 , Ercc2 , Ercc3 , Ercc4 , Ercc5 , Ercc6 , Ercc8 , Xpa Cockayne syndrome A Ercc8 Cockayne syndrome B Ercc6 colon cancer Pold1 , Pole colon carcinoma Pold1 , Pole Colonic Neoplasms Ccnh , Pcna , Rfc1 colorectal adenocarcinoma Ercc6 , Xrcc1 colorectal cancer Ercc1 , Ercc2 , Ercc3 , Ercc4 , Ercc6 , Pold1 , Pole , Xrcc1 Colorectal Cancer 10 Pold1 , Pole colorectal carcinoma Ercc6 , Pold1 , Pole , Xrcc1 Colorectal Neoplasms Ercc1 , Ercc2 , Ercc5 , Pold1 , Pold3 , Pole combined immunodeficiency Pold1 communication disorder Ddb1 congenital heart disease Ddb1 , Rfc1 Congenital Ichthyosis with Trichothiodystrophy Ercc2 congenital myopathy 1A Pold1 , Pole contact dermatitis Xrcc1 coronary artery disease Ercc2 , Ercc5 , Xrcc1 Craniofacial Abnormalities Ercc6 , Rad23b Crohn's disease Ercc2 De Sanctis-Cacchione syndrome Ercc6 Deafness Pold1 degenerative disc disease Ercc1 Desbuquois dysplasia Pole , Polr1a Developmental Disabilities Cul4b diabetic retinopathy Xrcc1 diffuse gastric cancer Ercc5 disease by infectious agent Ercc5 disease of cellular proliferation Ercc1 Disease Progression Ddb1 , Rad23a , Xpc Down syndrome Ercc2 , Ercc3 Drug-induced Neutropenia Ercc1 , Ercc2 , Ercc6 , Pold1 Drug-Related Side Effects and Adverse Reactions Ercc1 , Ercc2 Dwarfism Cul4b endometrial cancer Pole endometrial carcinoma Pold1 , Pole Endometrial Neoplasms Ercc2 , Pold1 Endometrioid Carcinomas Pole epidermolytic hyperkeratosis Ercc2 epilepsy Cul4b , Polk epilepsy with generalized tonic-clonic seizures Lig1 Erythema Xrcc1 esophageal cancer Xrcc1 Esophageal Neoplasms Ccnh esophagus adenocarcinoma Ercc1 esophagus squamous cell carcinoma Ercc1 , Xrcc1 Experimental Diabetes Mellitus Ercc1 , Ercc4 Experimental Mammary Neoplasms Ccnh , Pcna Experimental Neoplasms Pcna Experimental Radiation Injuries Pcna Experimental Seizures Xrcc1 Facial Dysmorphism, Immunodeficiency, Livedo, and Short Stature Pole Failure to Thrive Ercc1 familial adenomatous polyposis Pold1 , Pole familial adenomatous polyposis 2 Pold1 , Pole Fanconi anemia complementation group Q Ercc4 fibrosarcoma Ercc6 focal segmental glomerulosclerosis Pcna fragile X syndrome Ercc6 gallbladder cancer Xrcc1 Gallbladder Neoplasms Ercc2 gastric cardia adenocarcinoma Xrcc1 gastric cardia carcinoma Xrcc1 Gastrointestinal Neoplasms Ercc1 genetic disease Cul4b , Ddb2 , Ercc2 , Ercc3 , Ercc4 , Ercc6 , Ercc8 , Gtf2h5 , Lig3 , Polr1a , Rfc1 , Xpa , Xpc Genetic Predisposition to Disease Ercc1 , Ercc4 , Ercc5 Germ Cell and Embryonal Neoplasms Ercc1 , Ercc4 , Pcna glioblastoma Ccnh , Polk , Xrcc1 Growth Disorders Ercc6 Head and Neck Neoplasms Ercc2 Hearing Loss Ercc6 hepatitis A Xrcc1 hepatitis B Xrcc1 hepatoblastoma Ercc2 , Pcna hepatocellular carcinoma Ercc1 , Ercc2 , Pcna , Xrcc1 hereditary breast ovarian cancer syndrome Ercc6 , Ercc8 , Rfc1 Hereditary Neoplastic Syndromes Ercc3 , Ercc4 , Ercc5 , Pold1 , Pole , Xpc high grade glioma Ercc1 , Ercc2 , Ercc5 , Pole , Xrcc1 Human Viral Hepatitis Xrcc1 hypertension Xrcc1 hypogonadism Pold1 Hypomyelinating Leukodystrophy 27 Polr1a hypothyroidism Pcna hypotrichosis 1 Ercc2 IMAGEI Syndrome Pole immunodeficiency 120 Pold1 immunodeficiency 122 Pold3 immunodeficiency 96 Lig1 impotence Xrcc1 in situ carcinoma Xrcc1 Inflammation Ercc1 inflammatory bowel disease 1 Ercc2 inherited metabolic disorder Lig1 intellectual disability Cul4b , Pold1 , Pold4 Intestinal Neoplasms Xpa Intimal Hyperplasia Pcna invasive ductal carcinoma Pcna , Xrcc1 ischemia Pcna Jaw Abnormalities Pold1 kidney failure Ercc1 laryngeal carcinoma Xrcc1 Laryngeal Neoplasms Ercc1 laryngeal squamous cell carcinoma Xrcc1 larynx cancer Ercc5 , Ercc6 Leigh disease Ercc8 leiomyoma Pcna , Xrcc1 leukodystrophy Ercc2 Lewy body dementia Pcna lipodystrophy Ercc1 , Pold1 liver cancer Pcna , Xrcc1 liver cirrhosis Xrcc1 Liver Injury Pcna Liver Neoplasms Ccnh , Xpa , Xpc lung adenocarcinoma Ercc1 , Ercc6 , Pold1 , Rfc4 , Xpc , Xrcc1 lung cancer Ercc5 , Ercc6 , Pole , Xpc , Xrcc1 lung carcinoma Ercc1 , Ercc6 Lung Neoplasms Ercc1 , Ercc2 , Ercc3 , Ercc6 , Pcna , Xpc lung non-small cell carcinoma Ccnh , Ercc1 , Ercc2 , Ercc3 , Ercc5 , Ercc6 , Pole , Xpc , Xrcc1 lung squamous cell carcinoma Ercc6 , Pole Lymphatic Metastasis Ccnh lymphoma Ercc6 macular degeneration Ercc2 , Ercc6 male infertility Rad23b , Xrcc1 malignant mesothelioma Xrcc1 Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome Pold1 melanoma Ercc1 , Ercc2 , Ercc5 meningioma Xrcc1 Mesothelioma Xrcc1 microcephaly Ercc4 , Ercc6 Micrognathism Pold1 Micronuclei, Chromosome-Defective Ercc4 , Polk , Xpa , Xpc , Xrcc1 microphthalmia Ercc6 middle cerebral artery infarction Ercc6 , Lig3 , Xrcc1 mismatch repair cancer syndrome Pole mitochondrial DNA depletion syndrome 20 Lig3 MORIMOTO-RYU-MALICDAN NEUROMUSCULAR SYNDROME Rfc4 motor peripheral neuropathy Rfc1 Mouth Neoplasms Ercc2 , Xrcc1 mucositis Pcna Multiple Abnormalities Pold1 multiple myeloma Ercc1 , Ercc2 myelodysplastic syndrome Ercc2 , Xrcc1 myelofibrosis Ercc1 , Ercc2 Myeloid Leukemia, Chronic-Phase Ercc1 myoepithelioma Pole nasopharynx carcinoma Xrcc1 Neoplasm Invasiveness Xpc Neoplasm Metastasis Ercc1 , Ercc4 , Pcna , Xpc , Xrcc1 Neoplastic Cell Transformation Hmgn1 nephroblastoma Pcna Nervous System Malformations Ercc8 NESCAV syndrome Polr1a Nijmegen breakage syndrome Ercc6 obstructive jaundice Pcna Occupational Diseases Ercc2 , Xrcc1 oligospermia Cul4b , Gtf2h1 oral mucosa leukoplakia Ercc2 , Xrcc1 osteoarthritis Ercc1 osteoporosis Ercc1 , Pcna osteosarcoma Ercc1 , Rfc1 ovarian cancer Ddb2 , Ercc1 , Ercc2 , Ercc3 , Ercc4 , Pold1 , Pole , Xpa , Xpc Ovarian Neoplasms Ccnh , Ercc2 ovary epithelial cancer Ercc1 , Ercc2 pancreatic cancer Ercc1 , Ercc2 , Ercc4 , Lig3 , Xpc , Xrcc1 pancreatic carcinoma Ercc4 , Pold1 papillary thyroid carcinoma Xrcc1 peripheral nervous system disease Ercc1 , Ercc3 , Ercc4 photosensitive trichothiodystrophy Ercc2 photosensitive trichothiodystrophy 1 Ercc2 , Gtf2h5 photosensitive trichothiodystrophy 2 Ercc3 photosensitive trichothiodystrophy 3 Gtf2h5 Phyllodes Tumor Pcna polyneuropathy due to drug Ercc4 , Ercc6 Premature Aging Ercc1 , Ercc6 primary immunodeficiency disease Lig1 primary ovarian insufficiency 11 Ercc6 primary ovarian insufficiency 16 Ercc6 primary pulmonary hypertension Rfc1 progeria Ercc4 prostate cancer Ercc2 , Polk , Xrcc1 Prostatic Neoplasms Ccnh , Ercc1 , Ercc2 , Polk , Rad23b , Xrcc1 psoriasis Pcna Psychomotor Disorders Ercc6 Pulmonary Fibrosis and/or Bone Marrow Failure Syndrome, Telomere-Related, 6 Rpa1 Pulmonary Hypertension, Hypoxia-Induced Pcna Recurrence Ercc4 renal cell carcinoma Pcna , Xrcc1 Reperfusion Injury Ercc1 retinal disease Ercc8 Right Ventricular Hypertrophy Rfc1 Rubinstein-Taybi syndrome Rbx1 Salivary Gland Neoplasms Xrcc1 sciatic neuropathy Pcna seminoma Pcna , Xrcc1 senile cataract Ercc2 , Xrcc1 sensorineural hearing loss Ercc6 , Ercc8 serous cystadenocarcinoma Xpc Skin Abnormalities Ercc2 skin disease Ercc2 Skin Neoplasms Ercc2 , Xpa spastic ataxia Ercc4 Spinal Cord Injuries Ccnh Spinocerebellar Ataxias Ercc4 squamous cell carcinoma Ercc2 , Ercc6 , Xpc Stevens-Johnson syndrome Cul4a , Rbx1 stomach cancer Ercc1 , Ercc2 , Ercc4 , Ercc5 , Ercc6 , Pcna , Xrcc1 stomach carcinoma Xrcc1 Stomach Neoplasms Ddb1 , Ercc1 , Ercc2 , Rad23a , Xrcc1 stomatitis Xrcc1 Sturge-Weber syndrome Ccnh Sunburn Ercc2 syndromic intellectual disability Ddb1 syndromic X-linked intellectual disability 5 Cul4b syndromic X-linked intellectual disability Cabezas type Cul4b Teratozoospermia Cul4b , Gtf2h1 Testicular Neoplasms Ercc1 , Ercc4 , Pcna transient cerebral ischemia Ccnh , Ercc1 , Ercc6 , Pcna , Xrcc1 transitional cell carcinoma Xrcc1 trichothiodystrophy Ercc2 , Ercc3 type 2 diabetes mellitus Xrcc1 urinary bladder cancer Ercc2 , Ercc4 , Lig1 , Xrcc1 Uterine Cervical Neoplasms Ercc1 UV-sensitive syndrome Ercc6 , Ercc8 UV-Sensitive Syndrome 1 Ercc6 UV-Sensitive Syndrome 2 Ercc8 West Nile fever Rfc1 WHITE-KERNOHAN SYNDROME Ddb1 xeroderma pigmentosum Ddb1 , Ddb2 , Ercc2 , Ercc3 , Ercc4 , Ercc5 , Xpa , Xpc xeroderma pigmentosum group A Xpa , Xpc xeroderma pigmentosum group B Ercc3 xeroderma pigmentosum group C Ercc2 , Xpc xeroderma pigmentosum group D Ercc2 xeroderma pigmentosum group E Ddb2 xeroderma pigmentosum group F Ercc4 xeroderma pigmentosum group G Ercc5 XFE progeroid syndrome Ercc1 , Ercc4 , Pole